Literature DB >> 2117062

Acidic drug transport in vivo through the blood-brain barrier. A role of the transport carrier for monocarboxylic acids.

Y S Kang1, T Terasaki, A Tsuji.   

Abstract

The relationship of the transports between acidic drugs and monocarboxylic acids through the blood-brain barrier (BBB) was examined using the carotid artery injection technique in rats. The BBB uptakes of [3H]acetic acid and [14C]salicylic acid were significantly reduced by the presence of the respective unlabeled compounds, valproic acid, lactic acid, benzoic acid, nicotinic acid or beta-lactam antibiotics (benzylpenicillin, propicillin and cefazolin), but was not reduced by choline, phenylalanine and a basic drug, eperisone. A remarkable pH dependency was observed for the BBB uptake of [14C]salicylic acid at the pH region of 4.0 to 7.4. Interestingly, 10 mM of salicylic acid diminished significantly the pH dependent BBB uptake of [14C]salicylic acid. Similar results were obtained in the BBB uptake of [14C]nicotinic acid. No significant difference was observed in the transport of monocarboxylic acids through the BBB between normotensive Wistar KY rats (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP). From these observations, acidic drugs could be transported by a carrier-mediated system for monocarboxylic acids at the BBB and the transport system was not changed by the disease state.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117062     DOI: 10.1248/bpb1978.13.158

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  11 in total

Review 1.  Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.

Authors:  Akira Tsuji
Journal:  NeuroRx       Date:  2005-01

2.  Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure.

Authors:  Mikko Gynther; Lauri Peura; Monika Vernerová; Jukka Leppänen; Jussi Kärkkäinen; Marko Lehtonen; Jarkko Rautio; Kristiina M Huttunen
Journal:  Neurochem Res       Date:  2016-07-14       Impact factor: 3.996

3.  Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy.

Authors:  Fredrik Lauritzen; Edgar L Perez; Eric R Melillo; Jung-Min Roh; Hitten P Zaveri; Tih-Shih W Lee; Yue Wang; Linda H Bergersen; Tore Eid
Journal:  Neurobiol Dis       Date:  2011-08-10       Impact factor: 5.996

4.  Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies.

Authors:  Y Kido; I Tamai; M Okamoto; F Suzuki; A Tsuji
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

5.  Monocarboxylate transporter 1 is deficient on microvessels in the human epileptogenic hippocampus.

Authors:  Fredrik Lauritzen; Nihal C de Lanerolle; Tih-Shih W Lee; Dennis D Spencer; Jung H Kim; Linda H Bergersen; Tore Eid
Journal:  Neurobiol Dis       Date:  2010-11-25       Impact factor: 5.996

Review 6.  Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics.

Authors:  Magdalena Markowicz-Piasecka; Agata Markiewicz; Patrycja Darłak; Joanna Sikora; Santosh Kumar Adla; Sreelatha Bagina; Kristiina M Huttunen
Journal:  Neurotherapeutics       Date:  2022-04-07       Impact factor: 6.088

Review 7.  Role of monocarboxylate transporters in drug delivery to the brain.

Authors:  Nisha Vijay; Marilyn E Morris
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Qualitative Phytochemical Fingerprint and Network Pharmacology Investigation of Achyranthes aspera Linn. Extracts.

Authors:  Kouadio Ibrahime Sinan; Gokhan Zengin; Dimitrina Zheleva-Dimitrova; Ouattara Katinan Etienne; Mohamad Fawzi Mahomoodally; Abdelhakim Bouyahya; Devina Lobine; Annalisa Chiavaroli; Claudio Ferrante; Luigi Menghini; Lucia Recinella; Luigi Brunetti; Sheila Leone; Giustino Orlando
Journal:  Molecules       Date:  2020-04-23       Impact factor: 4.411

9.  Low Molecular Weight (poly)Phenol Metabolites Across the Blood-Brain Barrier: The Underexplored Journey.

Authors:  Rafael Carecho; Diogo Carregosa; Cláudia Nunes Dos Santos
Journal:  Brain Plast       Date:  2021-02-09

Review 10.  Drug interactions at the blood-brain barrier: fact or fantasy?

Authors:  Sara Eyal; Peng Hsiao; Jashvant D Unadkat
Journal:  Pharmacol Ther       Date:  2009-04-22       Impact factor: 13.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.